Evrys Bio, LLC
Pharmaceutical company · Doylestown, Pennsylvania, United States
Evrys Bio, LLC is a pharmaceutical company headquartered in Doylestown, Pennsylvania, United States. Its earliest recorded incorporation is in 2012. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $12 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $3.4 million sold in a notice filed in 2017.
Evrys Bio at a glance
What does Evrys Bio do?
US government research funding
9 SBIR/STTR small-business research awards from US health agencies, $12.1 million in total (2014 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3.4 million sold (2017).
Frequently asked questions about Evrys Bio
Where is Evrys Bio headquartered?
Evrys Bio, LLC is headquartered in Doylestown, Pennsylvania, United States.
What does Evrys Bio do?
Evrys Bio, LLC is a pharmaceutical company.
When was Evrys Bio founded?
The earliest incorporation on record for Evrys Bio, LLC is in 2012, according to public company registers.
Similar companies
- Aprea Therapeutics, Inc.Doylestown, Pennsylvania, United States
- Neuropathix, Inc.Doylestown, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences